Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor.
about
The Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Cardiovascular Homeostasis: A Non-Systematic Literature Review.PCSK9 and infection: A potentially useful or dangerous association?The Proprotein Convertases in Hypercholesterolemia and Cardiovascular Diseases: Emphasis on Proprotein Convertase Subtilisin/Kexin 9.PCSK9 at the crossroad of cholesterol metabolism and immune function during infections.The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation: A NOVEL MECHANISM CAUSING FAMILIAL HYPERCHOLESTEROLEMIA.Lipid testing in infectious diseases: possible role in diagnosis and prognosis.Curcumin Protects Against Intestinal Origin Endotoxemia in Rat Liver Cirrhosis by Targeting PCSK9.Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis.Lipopolysaccharide enters the rat brain by a lipoprotein-mediated transport mechanism in physiological conditions.Correction: Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor.Modeling hypercholesterolemia and vascular lipid accumulation in LDL receptor mutant zebrafish.PCSK9 inhibitors in sepsis: a new potential indication?Environmental Subconcussive Injury, Axonal Injury, and Chronic Traumatic Encephalopathy.Low-density lipoprotein (LDL)-dependent uptake of Gram-positive lipoteichoic acid and Gram-negative lipopolysaccharide occurs through LDL receptor.HDL inflammatory index correlates with and predicts severity of organ failure in patients with sepsis and septic shock
P2860
Q38637552-8E76BC7A-5AC2-4B6A-B38A-319986644093Q38748867-0A0C6F72-CC26-4FCE-BD94-72C57A5EE107Q39030028-2545FF7C-96AD-4741-BF65-D730BAA4ECD0Q39072663-8D169DDD-8FEC-4686-B546-DE4C0273E9FDQ39080645-05D6AC2F-4CDA-44CD-8443-3D1671AFDE5CQ39293001-C24F55EF-8AD9-4641-A9A7-9437DFE78FB1Q40333634-AAD8372A-B19E-4743-A2AC-CA30A71C9469Q41649308-D454E56F-80B8-41B5-AE41-28C1539A91EEQ42377215-3C434AC0-0899-4722-817B-520A3C8F506EQ42403040-15668CEC-7184-4209-8EAC-C90C639CB740Q46011787-1C5081CF-818E-482F-9D1C-A69045F0AB1FQ51266701-02E54448-2CF4-452F-8902-A20FC3A187C4Q52543744-B80CB31A-14EC-4D6F-9A42-FD11A3B820D2Q55715343-60B9FB77-05DB-4139-BF80-810C9B41145CQ57157407-FF57B2D0-1731-4A46-9B0A-529FFA714541
P2860
Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Lipopolysaccharide Is Cleared ...... Density Lipoprotein Receptor.
@ast
Lipopolysaccharide Is Cleared ...... Density Lipoprotein Receptor.
@en
type
label
Lipopolysaccharide Is Cleared ...... Density Lipoprotein Receptor.
@ast
Lipopolysaccharide Is Cleared ...... Density Lipoprotein Receptor.
@en
prefLabel
Lipopolysaccharide Is Cleared ...... Density Lipoprotein Receptor.
@ast
Lipopolysaccharide Is Cleared ...... Density Lipoprotein Receptor.
@en
P2093
P2860
P1433
P1476
Lipopolysaccharide Is Cleared ...... Density Lipoprotein Receptor.
@en
P2093
Elena Topchiy
HyeJin Julia Kong
James A Russell
John H Boyd
Keith R Walley
Mihai Cirstea
Yingjin Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0155030
P407
P577
2016-05-12T00:00:00Z